ClinicalTrials.Veeva

Menu

Muscle Relaxants on Efficacy of LMA Insertion (LMA_MR)

D

Daegu Catholic University Medical Center

Status

Completed

Conditions

Anesthesia Intubation Complication

Treatments

Drug: rocuronium
Drug: saline

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The use of laryngeal mask airway (LMA) is increasing in pediatric anesthesia because it provides lesser direct mechanical stimulation of the airway due to being placed above the larynx. However, LMA insertion can be more difficult in children than in adults due to their unique characteristics of pediatric airway. Neuromuscular blocking agents, so-called, muscle relaxants have long been used to facilitate insertion of airway devices. But there are pros and cons for the efficacy of muscle relaxants in LMA insertion, and most studies were investigated in adults.

Enrollment

128 patients

Sex

All

Ages

2 to 7 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children aged between 2 and 7 years of American Society of Anesthesiologists physical status (ASA PS) I or II who are planned to receive ophthalmic surgery under general anesthesia

Exclusion criteria

  • Refusal of consent
  • Present URI or other respiratory symptoms
  • Oro or facial anomaly
  • Poor dental condition
  • who cannot open their mouth or limited mouth opening
  • when the tracheal intubation is definitely needed

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

128 participants in 2 patient groups

MR group
Active Comparator group
Description:
When the patients asleep, 0.3 mg/kg rocuronium is administered.
Treatment:
Drug: rocuronium
NMR group
Experimental group
Description:
When the patients asleep, 0.3 mg/kg saline is administered.
Treatment:
Drug: saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems